Skip to content
2000
Volume 10, Issue 3
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

This work details recent advances in the science of estrogen receptor (ER) modulation, with emphasis on the discovery of novel ligands for the ER ligand binding domain (LBD). A detailed examination of structural studies of the ERs is presented with analysis of the impact of such works on contemporary ligand design and the molecular pharmacology of the ER. The various classes of ER modulators are discussed on the basis of stuctural similarities including selective estrogen receptor modulators (SERMs) and ‘pure’ nonsteroidal antiestrogens. Additionally we review the emergence of a novel selective class of modulator - which we have termed the selective estrogen receptor subtype modulators (SERSMs) and, in a departure from LBD strategies we examine the discovery of novel peptide inhibitors of the ER which inhibit transcriptional activiation of agonist liganded receptor through interaction with coactivator recruitment proteins, and offer unique insight to the mechanism of action of all classes of ER modulators. Through examination of patent and classical literature we present a thorough and informative cross-section of the contemporary state of the art in this exciting field of pharmaceutical research.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867033368501
2003-02-01
2025-04-12
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867033368501
Loading

  • Article Type:
    Review Article
Keyword(s): er; er modulation; estrogen receptor; lbd; ligand binding domain; sersms
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test